论文部分内容阅读
酮康唑(Ketoconazol)是治疗全身性真菌感染的咪唑类新型药物。国内使用以来已出现多例肝损害报道,其中一例死亡。国外在1981年已有肝损害报道。许多国家的有关药品安全机构均向医生发出警告,必须对酮康唑引起的肝脏反应进行严密监测。酮
Ketoconazol is a new class of imidazole that treats systemic fungal infections. Several cases of liver damage have been reported since domestic use, of which one case died. Foreign reports of liver damage have been reported in 1981. Drug safety agencies in many countries issue warnings to doctors that the liver response to ketoconazole must be closely monitored. ketone